FGFR Like1 drives esophageal cancer progression via EMT , PI3K /Akt, and notch signalling: insights from clinical data and next‐generation sequencing analysis
FEBS Open Bio · 2026
DOI: 10.1002/2211-5463.70167 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Open Bio, 2026. Verfasst von Aprajita Srivastava und 3 weiteren Autor:innen. Beteiligte Einrichtung: University School of Biotechnology, Guru Gobind Singh Indraprastha University, New Delhi, India. Hauptthemen laut MEDLINE: Esophageal Neoplasms. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India (SERB-DST), Guru Gobind Singh Indraprastha University.
Abstract (Originalsprache)
FGFRL1, one of the least explored FGFRs, has recently been shown to have implications in cancer, but its functional significance in esophageal cancer (EC) remains largely unexplored. We evaluated FGFRL1 expression in EC patients ( n = 106) using immunohistochemistry, observing a significant increase in preneoplastic and neoplastic tissues ( P < 0.001, OR = 73.2; AUC = 0.817). RNAi‐coupled next‐generation sequencing revealed enrichment of EMT, PI3K/Akt, and Notch pathways. Quantitative RT‐PCR validated the downregulation of top cluster and Notch pathway genes ( P < 0.05). Western blot showed decreased phospho‐GSK3β, phospho‐Akt, and mesenchymal markers. TCGA data supported a positive correlation with EMT. Functional assays demonstrated FGFRL1's oncogenic role, showing G1 phase arrest, and reduced proliferation, migration, and invasion ( P < 0.001). Our study highlights FGFRL1 as a key driver of EC progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University School of Biotechnology, Guru Gobind Singh Indraprastha University, New Delhi, India.
- Department of Gastroenterology, All India Institute of Medical Science, New Delhi, India.
ORCID-Profile: Rinu Sharma
Förderung
- Department of Science and Technology, Ministry of Science and Technology, India (SERB-DST)
- Guru Gobind Singh Indraprastha University
Zitieren
APA
Srivastava, A., Saraya, A., Gunjan, D., & Sharma, R. (2026). FGFR Like1 drives esophageal cancer progression via EMT , PI3K /Akt, and notch signalling: insights from clinical data and next‐generation sequencing analysis. FEBS Open Bio. https://doi.org/10.1002/2211-5463.70167
Vancouver
Srivastava A, Saraya A, Gunjan D, Sharma R. FGFR Like1 drives esophageal cancer progression via EMT , PI3K /Akt, and notch signalling: insights from clinical data and next‐generation sequencing analysis. FEBS Open Bio. 2026. doi:10.1002/2211-5463.70167
BibTeX
@article{Srivastava2026,
author = {Srivastava, Aprajita and Saraya, Anoop and Gunjan, Deepak and Sharma, Rinu},
title = {FGFR Like1 drives esophageal cancer progression via EMT , PI3K /Akt, and notch signalling: insights from clinical data and next‐generation sequencing analysis},
journal = {FEBS Open Bio},
year = {2026},
doi = {10.1002/2211-5463.70167}
}
EUVIMED